4-hydroxy-4-methyl-piperidine-1-carbox ylic acid (4-methoxy-7-morpholin-4-yl-benzothia zol-2-yl)-amide

Details for Australian Patent Application No. 2005247567 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Steward, Lucinda; Riemer, Claus; Flohr, Alexander; Moreau, Jean-Luc; Poli, Sonia Maria

Agent Spruson & Ferguson

Pub. Number AU-B-2005247567 (Modified Examination)

PCT Pub. Number WO2005/116026

Priority 04102262.5 24.05.04 EP

Filing date 17 May 2005

Wipo publication date 8 December 2005

Acceptance publication date 2 September 2010

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/116026 Priority application(s): WO2005/116026

2 September 2010 Application Accepted

  Published as AU-B-2005247567 (Modified Examination)

6 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247588-Thioether derivatives, their manufacture and use as pharmaceutical agents

2005247565-Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof